Tag: iCAD
iCAD Announces FDA Clearance for ProFound AI Version 3.0 for 3D...
Company’s third generation AI solution offers significant improvement in algorithm specificity performance and faster processing compared to previous versions of the software ...
iCAD to Participate in the Cowen 41st Annual Health Care Conference
NASHUA, N.H., March 03, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection...
iCAD Announces Pricing of $22.0 Million Public Offering of Common Stock
NASHUA, N.H., March 03, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (the “Company”, NASDAQ: ICAD), a global medical technology leader providing innovative...